The Translational Genomics Research Institute

FDA approves new therapy for pancreatic cancer patients

Patients with advanced pancreatic cancer now have access to the new FDA approved drug, Onivyde, that produced significant overall survival rates in an international clinical study conducted in part by researchers at HonorHealth ...

Oct 26, 2015
popularity12 comments 0